Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

WP 833

Known as: WP-833 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
WP-833 is an orally active new antiallergic drug. The effects of WP-833 metabolites on experimental allergic reactions were… Expand
Is this relevant?
1990
1990
 
Is this relevant?
1989
1989
 
Is this relevant?
1988
1988
The inhibitory effects of butyl 3'-(1H-tetrazol-5-yl) oxanilate (WP-833), a new antiallergic drug, on histamine release from lung… Expand
Is this relevant?
1988
1988
The effects of butyl 3'-(1H-tetrazol-5-yl)oxanilate (WP-833), a new antiallergic drug, on type I to type IV allergic reactions… Expand
Is this relevant?
1988
1988
The effects of butyl 3'-(1H-tetrazol-5-yl)oxanilate (WP-833), a new antiallergic drug, on its ability to inhibit histamine… Expand
Is this relevant?
1988
1988
The effects of butyl 3'-(1H-tetrazol-5-yl)oxanilate (WP-833), a new antiallergic drug, on immunological reactions in mice and… Expand
Is this relevant?
1988
1988
The effects of butyl 3'-(1H-tetrazol-5-yl)oxanilate (WP-833), a new antiallergic drug, on histamine release from human leukocytes… Expand
Is this relevant?